Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

AZD2171 to Treat Children and Adolescents With Solid Tumors or Acute Myelogenous Leukemia

This study has been completed.
Information provided by:
National Institutes of Health Clinical Center (CC) Identifier:
First received: May 3, 2006
Last updated: October 9, 2014
Last verified: June 2012